Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China flag China · Delayed Price · Currency is CNY
30.71
-1.93 (-5.91%)
At close: Jan 29, 2026

SHE:301089 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
69.5669.23148.55307.09284.22158.22
Trading Asset Securities
185.28250.88190.7240.16220.62-
Cash & Short-Term Investments
254.83320.11339.26547.25504.84158.22
Cash Growth
-28.75%-5.64%-38.01%8.40%219.08%52.49%
Accounts Receivable
132.45151.52235.3205.41103.5892.11
Other Receivables
0.221.3212.5713.660.620.28
Receivables
132.65172.84247.87219.07104.292.39
Inventory
190.79178.88204.11241.14167.08159.9
Other Current Assets
30.125.1830.936.5420.644.41
Total Current Assets
608.39677.01822.171,014796.76414.91
Property, Plant & Equipment
860.66874.54809.38610.26449.11415.14
Long-Term Investments
17.957.958.3710.8612.5415.62
Other Intangible Assets
79.7381.8384.0484.2684.5671.02
Long-Term Accounts Receivable
0.270.26----
Long-Term Deferred Tax Assets
75.4769.5863.7170.366.517.66
Long-Term Deferred Charges
2.8742.71.862.338.01
Other Long-Term Assets
44.0243.0848.6251.6441.914.11
Total Assets
1,6891,7581,8391,8431,394946.48
Accounts Payable
103.41133.21152.55158.58162.94213.38
Accrued Expenses
8.2922.8124.5869.0917.5121.08
Short-Term Debt
---40.0364.5147.41
Current Portion of Leases
0.880.97--4.9118.44
Current Income Taxes Payable
2-066.051.312.37
Current Unearned Revenue
2.970.915.4871.892.915.66
Other Current Liabilities
12.37.4311.918.320.532.15
Total Current Liabilities
129.84165.32194.51423.96254.6420.5
Long-Term Debt
-----4.8
Long-Term Leases
2.343.25---4.91
Long-Term Unearned Revenue
31.432.9435.1738.3140.423.57
Long-Term Deferred Tax Liabilities
3.424.216.044.611.361.83
Total Liabilities
167.01205.72235.72466.89296.35455.61
Common Stock
126.54126.54126.5412612694.5
Additional Paid-In Capital
621.11621.11621.11585.3578.5466.77
Retained Earnings
772.49802.66854.18661.5387.57321.86
Comprehensive Income & Other
2.212.211.443.575.257.75
Total Common Equity
1,5221,5531,6031,3761,097490.87
Shareholders' Equity
1,5221,5531,6031,3761,097490.87
Total Liabilities & Equity
1,6891,7581,8391,8431,394946.48
Total Debt
3.224.22-40.0369.41175.56
Net Cash (Debt)
251.61315.89339.26507.22435.43-17.34
Net Cash Growth
-29.65%-6.89%-33.11%16.49%--
Net Cash Per Share
2.112.542.694.024.37-0.18
Filing Date Shares Outstanding
126.54126.54126.5412612694.5
Total Common Shares Outstanding
126.54126.54126.5412612694.5
Working Capital
478.55511.69627.66590.04542.16-5.59
Book Value Per Share
12.0312.2712.6710.928.715.19
Tangible Book Value
1,4431,4711,5191,2921,013419.85
Tangible Book Value Per Share
11.4011.6212.0110.258.044.44
Buildings
-283.94267.66257.26210.62101.8
Machinery
-420.02382.3354.84301.65195.05
Construction In Progress
-372.68331.03130.4835.59266.05
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.